Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (570) Arrow Down
Filter Results: (570) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,107)
    • People  (1)
    • News  (264)
    • Research  (570)
    • Events  (1)
    • Multimedia  (16)
  • Faculty Publications  (306)

Show Results For

  • All HBS Web  (1,107)
    • People  (1)
    • News  (264)
    • Research  (570)
    • Events  (1)
    • Multimedia  (16)
  • Faculty Publications  (306)
← Page 15 of 570 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • March 2023
  • Teaching Note

VideaHealth: Building the AI Factory

By: Karim R. Lakhani
Teaching Note for HBS Case No. 621-021. The case “VideaHealth: Building the AI Factory” examines the creation of dental startup VideaHealth (Videa) and the development of its artificial intelligence (AI)-led business strategy through the eyes of founder and CEO Florian... View Details
Keywords: AI and Machine Learning; Applications and Software; Business Model; Marketing Strategy; Product Development; Health Industry; Health Industry
Citation
Purchase
Related
Lakhani, Karim R. "VideaHealth: Building the AI Factory." Harvard Business School Teaching Note 623-073, March 2023.
  • Article

Four Things No One Will Tell You About ESG Data

By: Sakis Kotsantonis and George Serafeim
As the ESG finance field and the use of ESG data in investment decision-making continue to grow, the authors seek to shed light on several important aspects of ESG measurement and data. This article is intended to provide a useful guide for the rapidly rising number of... View Details
Keywords: ESG; ESG (Environmental, Social, Governance) Performance; ESG Reporting; Data Analytics; Sustainability; Sustainability Reporting; CSR; Transparency; Investment Management; Socially Responsible Investing; Sustainable Finance; Sustainable Development; Inclusion; Inclusive Growth; Corporate Social Responsibility and Impact; Corporate Accountability; Investment; Management; Climate Change; Corporate Governance; Diversity; Integrated Corporate Reporting
Citation
Find at Harvard
Read Now
Related
Kotsantonis, Sakis, and George Serafeim. "Four Things No One Will Tell You About ESG Data." Journal of Applied Corporate Finance 31, no. 2 (Spring 2019): 50–58.
  • 16 Apr 2019
  • First Look

New Research and Ideas, April 16, 2019

including patients, physicians, employers, insurance companies, and the government need to recognize that value is best defined as “a given health outcome per dollar of cost expended.” In this article, we... View Details
Keywords: Dina Gerdeman
  • 09 Mar 2009
  • Research & Ideas

How to Revive Health-Care Innovation

The patient is weak, the situation is serious, but a cure is on the horizon—if we think differently about the underlying problem. Specifically, we need to innovate in health care just the way it is done in any other industry, by tackling... View Details
Keywords: by Clayton M. Christensen, Jerome H. Grossman, M.D. M.D. & Jason Hwang; Health
  • April 2017
  • Case

China Hospitals Inc.: The Growth of Private Hospitals in China

By: Kevin Schulman, Xiao Yu and Ariel Hwang
This case examines the privatization of hospitals in China. China Hospitals, Inc. has become the largest for-profit hospital company in China, purchasing government owned hospitals in Tier 2 cities. The case profiles CEO Frank Hu. To build his company, he has to... View Details
Keywords: Privatization; For-Profit Firms; Growth and Development Strategy; Business Model; Health Industry; China
Citation
Educators
Purchase
Related
Schulman, Kevin, Xiao Yu, and Ariel Hwang. "China Hospitals Inc.: The Growth of Private Hospitals in China." Harvard Business School Case 317-104, April 2017.
  • November 2020 (Revised April 2021)
  • Case

Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care

By: Trevor Fetter and Kira Seiger
This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in... View Details
Keywords: Business Ventures; Acquisition; Mergers and Acquisitions; Business Model; Change; Disruption; Fluctuation; Trends; Customers; Customer Value and Value Chain; Ethics; Fairness; Finance; Equity; Insurance; Private Equity; Geography; Geographic Scope; Health; Health Care and Treatment; Markets; Demand and Consumers; Supply and Industry; Industry Structures; Ownership; Ownership Type; Private Ownership; Relationships; Agency Theory; Business and Community Relations; Business and Shareholder Relations; Business and Stakeholder Relations; Networks; Strategy; Competition; Consolidation; Expansion; Integration; Horizontal Integration; Vertical Integration; Value; Value Creation; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Fetter, Trevor, and Kira Seiger. "Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care." Harvard Business School Case 321-049, November 2020. (Revised April 2021.)
  • September 2011
  • Supplement

Narayana Hrudayalaya Heart Hospital

By: Tarun Khanna and Tanya Bijlani
Narayana Hrudayalaya (NH) is one of the world's busiest heart hospitals, where surgeons perform 30-35 complex cardiac surgeries daily. With an average cost of $1,800 per surgery, the hospital treats patients at affordable prices, and does not turn away even the poorest... View Details
Keywords: Buildings and Facilities; Experience and Expertise; Cost Management; Insurance; Health Care and Treatment; Resource Allocation; Time Management; Emerging Markets; Infrastructure; Cooperative Ownership; Quality; Social Enterprise; Health Industry; Karnataka
Citation
Purchase
Related
Khanna, Tarun, and Tanya Bijlani. "Narayana Hrudayalaya Heart Hospital." Harvard Business School Multimedia/Video Supplement 712-802, September 2011.
  • 21 May 2012
  • Research & Ideas

OSHA Inspections: Protecting Employees or Killing Jobs?

With an election looming and the economy continuing to struggle, the effectiveness of government regulation has become a political football. While advocates hold regulations up as necessary to protect public health and safety, critics see... View Details
Keywords: by Michael Blanding
  • April 1995 (Revised August 1995)
  • Case

Empire Blue Cross and Blue Shield (A)

By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company. View Details
Keywords: Governing and Advisory Boards; Corporate Governance; Financial Condition; Organizational Culture; Problems and Challenges; Nonprofit Organizations; Insurance Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (A)." Harvard Business School Case 195-216, April 1995. (Revised August 1995.)
  • 27 Sep 2011
  • First Look

First Look: September 27

healthcare spending in 2015 and 2020, especially for expenditures on prescription drugs in nominal terms and as a percentage of overall health spending. The article concludes with a discussion of the political economy of View Details
Keywords: Sean Silverthorne
  • March 2008
  • Case

Novartis AG: Science-Based Business

By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details
Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
  • July 2023
  • Case

DayTwo: Going to Market with Gut Microbiome (Abridged)

By: Ayelet Israeli
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in... View Details
Keywords: Business Startups; AI and Machine Learning; Nutrition; Market Entry and Exit; Product Marketing; Distribution Channels
Citation
Educators
Purchase
Related
Israeli, Ayelet. "DayTwo: Going to Market with Gut Microbiome (Abridged)." Harvard Business School Case 524-015, July 2023.
  • 24 Jan 2017
  • First Look

First Look at New Research: January 24, 2017

industry observers believed the growth and consolidation would continue, providing many opportunities for investors. However, few health club chains were publicly listed, and the leading listed company, Bally Total Fitness, was under U.S.... View Details
Keywords: Sean Silverthorne
  • November 2007
  • Case

Antegren: A Beacon of Hope

By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
  • June 2010 (Revised September 2010)
  • Case

athenahealth: Innovating in Response to a Crisis in Healthcare

When Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Information Management; Innovation and Invention; Brands and Branding; Product Development; Health Industry; United States
Citation
Educators
Purchase
Related
Chakravorti, Bhaskar, Laura Winig, and Naeem Husain Arastu. "athenahealth: Innovating in Response to a Crisis in Healthcare." Harvard Business School Case 810-079, June 2010. (Revised September 2010.)
  • Winter 2022
  • Article

Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities

By: Eric Budish, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast and Andrew A. Torkelson
By January 2022, the COVAX international vaccine collaboration had allocated over a billion vaccines to over 140 countries. We describe and review the allocation process chosen, which reflected both an objective of equitably distributing vaccines across the world and... View Details
Keywords: Vaccines; Pandemics; Health Care and Treatment; Health Pandemics; Distribution; Supply Chain; Equality and Inequality
Citation
Find at Harvard
Purchase
Related
Budish, Eric, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast, and Andrew A. Torkelson. "Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities." Oxford Review of Economic Policy 38, no. 4 (Winter 2022): 941–974.
  • January 2023
  • Case

Thomas Buberl: Refounding AXA

By: Hubert Joly, Mihir Desai and Amram Migdal
In 2022, AXA and its CEO Thomas Buberl faced new types of challenges, including systemic risks such as climate change, geopolitical instability, public health crises, and social tensions caused by economic risks. AXA was one of the world’s largest insurers. Since... View Details
Keywords: Change; Change Management; Transformation; Transition; Trends; Environmental Management; Climate Change; Ethics; Values and Beliefs; Finance; Insurance; Management; Management Succession; Risk Management; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Planning; Strategic Planning; Risk and Uncertainty; Society; Human Needs; Social Issues; Strategy; Adaptation; Business Strategy; Corporate Strategy; Insurance Industry; Europe; France; Paris
Citation
Educators
Purchase
Related
Joly, Hubert, Mihir Desai, and Amram Migdal. "Thomas Buberl: Refounding AXA." Harvard Business School Case 523-059, January 2023.
  • 30 Jul 2013
  • First Look

First Look: July 30

Participation of Disability Insurance Applicants By: Shu, Pian Abstract—Using panel data from the RAND Health and Retirement Study, I show that rejected applicants for Social Security Disability View Details
Keywords: Anna Secino
  • July 2024
  • Case

Replika AI: Alleviating Loneliness (A)

By: Shikhar Ghosh and Shweta Bagai
Eugenia Kuyda launched Replika AI in 2017 as an empathetic digital companion to combat loneliness and provide emotional support. The platform surged in popularity during the COVID-19 pandemic, offering non-judgmental support to isolated users. By 2023, Replika boasted... View Details
Keywords: Entrepreneurship; Ethics; Health Pandemics; AI and Machine Learning; Well-being; Technology Industry
Citation
Educators
Purchase
Related
Ghosh, Shikhar, and Shweta Bagai. "Replika AI: Alleviating Loneliness (A)." Harvard Business School Case 824-088, July 2024.
  • January 2015 (Revised July 2019)
  • Case

CVS Health: Promoting Drug Adherence

By: Leslie John, John Quelch and Robert Huckman
Email mking@hbs.edu for a courtesy copy.

The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
  • ←
  • 15
  • 16
  • …
  • 28
  • 29
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.